Director, Government Pricing & Contracting Analytics
United States · On-site
$213k–$258k/yr
Senior
Overview The Director, Market Access & Government Pricing Analytics is responsible for oversight of all government pricing calculations. He/she will work closely with cross functional teams to evaluate impacts to governm…
Skills: Government pricing, Market access, Financial modeling, Forecasting, Contract development
Overview This is a critical leadership position dedicated to driving market access, pricing strategy, and contracting for our best-in-class oncology and hematology therapies. In this high-impact role, you will spearhead …
Executive Assistant – Clinical Development and Medical Affairs (CDMA)
New York, United States · On-site
$116k–$138k/yr
Senior
Overview Executive Assistant – Clinical Development and Medical Affairs (CDMA) Reports to VP, Head of Medical Affairs, Solid Tumors Opportunity This is a great opportunity for an experienced administrator to join Menarin…
Overview Menarini Stemline is hiring a Territory Manager, Breast Cancer/Solid Tumor. The Territory Manager is responsible for the sale and support of Stemline products to both existing and potential customers. The goals …
External Quality Lead (Senior Manager/Associate Director, commensurate with experience)
New York, United States · On-site
$140k–$180k/yr
Senior
Overview Sr. Manager/ Associate Director External Quality Lead Reports to Director Product Quality Lead The External Quality Lead (EQL) provides the tactical, "day-to-day" Quality oversight of our external manufacturing …
Skills: Quality Assurance, Sterile Manufacturing, cGMP, FDA Regulations, EU Regulations
Overview Position Title: IT AI Product Owner Reports to: Head of AI Engineering Our company is seeking an IT AI Product Owner to support the operation and continuous improvement of our AI-enabled business solutions/produ…
Skills: Generative AI, Product Ownership, Business Analysis, Agile, Scrum
Overview Menarini Stemline is hiring a Territory Manager, Breast Cancer/Solid Tumor. The Territory Manager is responsible for the sale and support of Stemline products to both existing and potential customers. The goals …
Skills: Oncology, Sales, Strategic Business Planning, Relationship Management, CRM
Oncology Territory Manager, Solid Tumor (New Orleans)
Louisiana, United States · On-site
$180k–$220k/yr
Senior
Overview Menarini Stemline is hiring a Territory Manager, Breast Cancer/Solid Tumor. The Territory Manager is responsible for the sale and support of Stemline products to both existing and potential customers. The goals …
Overview The Grant Associate will join the Corporate Grants & Funding Department, based in Florence. This position plays a key role in supporting the development and management of funding initiatives at European, nationa…
Skills: Grant writing, Budget tracking, Administrative support, Project management, Reporting
Global Application & Processes Specialist (Finance, Procurement & Audit)
Florence, Tuscany, Italy · On-site
Mid level
Overview The ideal candidate is an IT/Business professional with a strong finance and accounting background and proven experience in managing IT projects related to Finance and Procurement processes. The role requires ef…
Skills: Project Management, Process Design, Vendor Management, Business Analysis, Finance Process Knowledge
Overview Menarini’s Global Compliance Department is a trusted partner in promoting and supporting an ethical work environment and a culture of compliance with the ultimate aim to pursue Menarini Group’s mission and prote…
Skills: Compliance, Business Ethics, Contract Review, Risk Management, Data Privacy
Overview The main focus is the management of the e-learning platform m-Learning. As a part of Global Training Dept, the Training Solutions function is focused in identifying, implementing and managing all the training re…
Skills: E-learning management, LMS administration, Cornerstone, Technical support, Training tools
Overview The Project Management Department is part of CODIFI’s Service Operations and Digital Channels division and works closely with teams across the Company to support the delivery of strategic initiatives. As our bus…
Overview The Director, Clinical & Value Evidence Liaison is a field-facing role within Medical Affairs whose main objective is to be a trusted scientific partner to key external payer and other population health decision…
Skills: Clinical evidence, Value evidence, HEOR, RWE, Account management
(Senior) Medical Director, Clinical Development, Solid Tumors
New York, New York, United States · Hybrid
$280k–$350k/yr
Senior
Overview The Medical Director, Clinical Development Solid Tumor will be responsible for driving the global clinical development strategy in solid tumors. The incumbent will be responsible for providing critical input int…
Skills: Clinical development, Oncology, Solid tumors, Medical monitoring, Clinical study protocols
Overview We are seeking a Clinical Scientist (Director/Senior Director), to join our Solid Tumor Clinical Development department. This role contributes/leads to the development, evaluation, planning, and execution of cli…
Overview Global Head of Medical Writing - AI Reports to SVP, Global Head of Clinical Sciences and Operations We are seeking a visionary and strategic Global Head of Medical Writing to lead our worldwide medical writing o…
Overview The Associate Director, Commercial Applications is a high-impact individual contributor responsible for providing strategic expertise and hands-on oversight for the implementation, integration, and maintenance o…
Overview Menarini Stemline is hiring a Territory Manager, Breast Cancer/Solid Tumor. The Territory Manager is responsible for the sale and support of Stemline products to both existing and potential customers. The goals …
Overview The Oncology Access Director will develop and expand relationships with population health decision makers at priority accounts (including large community practices, select academic medical centers/health systems…
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
$213k–$258k/yr
Full-time
bachelor degree
Short-term Incentive Program, Long-term Incentive Program, 401(k) with 6% company match, Anthem Premier PPO insurance, HDHP insurance, Company paid Basic Life insurance
Posted 8h ago
Apply by Aug 11
~40 hrs/week
Responsibilities
The Director oversees all government pricing calculations, submissions, and reporting to ensure compliance with federal programs. They also partner with cross-functional teams to develop market access strategies and manage gross-to-net forecasts for the oncology portfolio.
Requirements
Candidates must possess a bachelor's degree and at least 5 years of relevant healthcare business experience within the pharmaceutical industry. Strong analytical, financial modeling, and communication skills are required to manage complex government pricing and contracting strategies.
Full job description
Overview
The Director, Market Access & Government Pricing Analytics is responsible for oversight of all government pricing calculations. He/she will work closely with cross functional teams to evaluate impacts to government pricing and will participate in analyses to support market access channel strategies, including managing bottoms up model and gross-to-net forecast. This individual is expected to establish and maintain collaborative working relationships with internal/external contacts and peers to ensure effective communication and a high-level of customer service.
Responsibilities
Responsibilities
Oversight of all government pricing calculations, analyses, and submissions, including Average Selling Price (ASP), Average Manufacturer’s Price (AMP), Best Price (BP), Public Health Service (PHS)/340B pricing, Non-Federal Average Manufacturer’s Price (Non-FAMP), Federal Ceiling Price (FCP), and Federal Supply Schedule prices (FSS) in accordance with the Medicaid Drug Rebate Program and all Federal Program Guidelines
Partner with key stakeholders to ensure timely and accurate filing of all government reporting to avoid significant monetary penalties assessed by various government agencies for late or inaccurate reporting
Represent Market Access on cross-functional teams to evaluate issues impacting government pricing and prepare analyses to understand the impact of new pricing and contracting strategies on Government Pricing calculations
Ensure compliance with laws governing government programs, including Medicaid, are within written policies, procedures, and standards of conduct
Maintains an understanding of the marketplace and changes that may impact government price reporting and government channel strategy.
Responsible for maintenance of documentation and procedures regarding government pricing, as well as internal and external audits
Inform brand forecasts including account and channel-level gross to net projections, Medicaid Unit forecasts, and government impact of proposed strategy changes (CPI penalties, Medicaid Mandated Rebate, BP)
Responsible for managing bottoms up model for in-line and launch products, including forecasting brand gross-to-net deductions
Provide GPO contracting support, including pre and post deal analyses
Participate in analyses to understand impact of market events on government price reporting and development of channel strategies (i.e. assessment of pipeline products coverage, analysis of impact of payer coverage policies, and provider/channel economics)
Proactively seeks and recommends enhancements and improvements in Market Access processes, including recommending resources, new approaches, negotiating agreeable solutions, or involving next-level management as needed.
Responsible for shaping and monitoring the evolution of the market access and government policy landscape in the short, near, and long-term.
Qualifications
Skills/Knowledge
Bachelor’s degree; preferably in a relevant field (Marketing, Science, Economics, finance or related field)
5 years of related healthcare business experience in pharmaceutical industry
In depth understanding in Government Pricing, Market Access and Healthcare delivery.
Analytical skills including problem solving, forecasting, contract development and financial modeling.
Demonstrated negotiation and relationship building skills.
Demonstrated ability to manage multiple priorities
Strong oral and written communication skills, including a strong focus on customer service
Base Salary Range of $213,000-$258,000. Menarini Stemline offers generous compensation and benefits packages, including Short- and Long-Term Incentive Programs, Fidelity 401(k) (with 6% company match), Anthem Premier PPO and HDHP insurance plans, Company paid Basic Life & AD&D insurance and pre-tax FSA/HSA programs.
Menarini Stemline is committed to creating an inclusive environment for all employees. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
About us:
Reasonable accommodations may be made to enable qualified individuals with disabilities to perform the essential functions.
Founded in 1886 in Naples under the name of Farmacia Internazionale, Menarini moved in 1915 to Florence where the Group’s headquarters are still located today. High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with nearly 135 years of history.
The Menarini Group is present in 70 countries and our products are sold in 140 locations around the world. Its companies span from Europe to Asia, to Africa and the Middle East, to Central America and to the United States where with the acquisition of Stemline Therapeutics, a NASDAQ-listed biopharmaceutical company, the company marked its entry into the US oncology market.
Thanks to the valuable contribution of around 18,000 employees, every year more than 500 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients distributed across 6 continents.
Menarini has made a strong commitment to oncology, investing in a pipeline of five investigational compounds for the treatment of a variety of haematological and solid tumours. The acquisition of Stemline Therapeutics in June 2020, further strengthened Menarini’s oncology portfolio, adding both commercial and clinical-stage assets. Tagraxofusp is a novel, first in class targeted therapy for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and to date, the only approved treatment for BPDCN in the U.S. and EU, and the first and only approved CD123-targeted therapy. Tagraxofusp is also being evaluated as both a single agent and in combination, in other CD123+ indications, including acute myeloid leukaemia (AML), chronic myelomonocytic leukaemia (CMML), and myelofibrosis (MF).
Additionally, Menarini received exclusive rights to commercialise Selinexor for the treatment of oncology indications in the European Union and other European countries (including the United Kingdom), Latin America and other key countries. Menarini has signed an exclusive licensing agreement with Karyopharm Therapeutics for the rights to commercialise an innovative therapeutic option in Europe, Latin America, Turkey, Russia, and CIS countries. Selinexor is a first-in-class, oral Selective Inhibitor of Nuclear export compound for the treatment of hematologic cancers and solid tumours. It is already marketed in the US for multiple myeloma and is under development for solid tumour indications. Selinexor is registered in the EU for both early and late lines.
Menarini entered into a global licence agreement with Radius Health to complete the development of Elacestrant, an oral SERD in late-stage Phase 3 development for hormone receptor-positive advanced breast cancer. Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority review and successfully oversaw a strong launch in February to the US market with the EMA review process concluded positively in September 2023.
It is an exciting time in the company’s development and an excellent opportunity for individuals joining us to contribute to building and shaping Menarini Stemline’s Oncology business.
Related keywords
Government PricingMarket AccessASPAMPBest Price340BMedicaid Drug Rebate ProgramGross-to-netFinancial ModelingForecastingOncologyPharmaceuticalComplianceContractingGPOFSS
The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees.
With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics.
The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.
For further information, please visit www.menarini.com
For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group
For reading our Privacy Notice for social networks users, please
visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
Offices: Via dei Sette Santi 1/3, Firenze, Italy 50131, IT
ALLERGOLOGYANDROLOGYANTINFECTIVE AREACARDIOVASCULAR AREASGASTROINTESTINAL DISORDERSGYNECOLOGY AND WOMEN'S WELLNESSPAINTRAUMA AND HEADACHESRESPIRATORY AREAREUMATOLOGY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees.
With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics.
The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.
For further information, please visit www.menarini.com
For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group
For reading our Privacy Notice for social networks users, please
visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
Offices: Via dei Sette Santi 1/3, Firenze, Italy 50131, IT
ALLERGOLOGYANDROLOGYANTINFECTIVE AREACARDIOVASCULAR AREASGASTROINTESTINAL DISORDERSGYNECOLOGY AND WOMEN'S WELLNESSPAINTRAUMA AND HEADACHESRESPIRATORY AREAREUMATOLOGY